These individual unimolecular multi-agonists activities seemed to harmonize the overall metabolic efficacy, which predominantly results from synergistic glucagon action to increase energy expenditure, GLP-1 action to reduce caloric intake and improve glucose control, and GIP action to potentiate the incretin effect and buffer against the diabetogenic effect of inherent glucagon activity
doi: 10.3389/fimmu.2021.648754
Studies have demonstrated that when combined with diet and exercise, Ozempic can lead to significant weight loss
Improved Metabolic Health Weight loss with tirzepatide is associated with improvements in various metabolic parameters, including lower blood pressure, improved cholesterol levels, and better blood glucose control
Headaches are also relatively common
It is specifically approved to improve blood sugar control in adults with type 2 diabetes and to reduce the risk of major cardiovascular events, such as heart attack or stroke, in patients with established heart disease
